Z Diamant, JT Hiltermann, EL van Rensen, PM Callenbach, M Veselic-Charvat, H van der Veen, JK Sont and PJ Sterk
Department of Pulmonology, Leiden University Medical Centre, The Netherlands.

The cysteinyl leukotriene LTE4 has been shown to induce airway eosinophilia in asthmatics in vivo. This phenomenon has not yet been reported for LTD4. Hence, we examined the effect of inhaled LTD4 and a control bronchoconstrictor agent, methacholine, on cell differentials in hypertonic saline-induced whole sputum samples of 12 nonsmoking atopic asthmatic subjects (three women, nine men; 21 to 29 yr of age; FEV1, 74 to 120% pred; PC20FEV1 methacholine < 9.6 mg/ml). The study had a cross-over, placebo-controlled design consisting of 4 d separated by > or = 1 wk. On each randomized study day, the subjects inhaled five serial doses of either LTD4 (mean cumulative concentration: 95.7 microM) or methacholine (mean cumulative concentration: 542 mM) or five doses of their respective diluents (PBS/ethanol or PBS). The airway response was measured by FEV1, followed by sputum induction with 4.5% NaCl, 4 h postchallenge. Inflammatory cells (> or = 250) were counted twice on coded cytospins and expressed as percentages of nonsquamous cells. There was no significant difference in the maximal percent fall in FEV1 from baseline between LTD4 (mean +/- SEM, 49.5 +/- 4.4% fall) and methacholine (mean +/- SEM, 55.9 +/- 3.4% fall) (p = 0.11). LTD4 induced a significant increase in the percentage of sputum eosinophils as compared with its diluent (mean +/- SD, 26.6 +/- 21.3% and 10.2 +/- 8.8%, respectively; p = 0.025), whereas a similar trend for methacholine failed to reach significance (mean +/- SD, 19.1 +/- 22.9% and 7.8 +/- 5.8%, respectively; p = 0.11). There was no significant difference in the changes in the percentage of sputum eosinophils between LTD4 and methacholine (mean difference +/- SD, 7.5 +/- 12.5% eosinophils; p = 0.09). We conclude that LTD4 induces eosinophilia in sputum of asthmatic subjects 4 h after inhalation. Our data suggest that LTD4 recruits eosinophils into the airways of asthmatics in vivo, possibly by virtue of direct or indirect chemotactic properties, whereas an additional effect of vigourous airway narrowing per se cannot be excluded.

This article has been cited by other articles:

				K. Chibana, Y. Ishii, T. Asakura, and T. Fukuda Up-Regulation of Cysteinyl Leukotriene 1 Receptor by IL-13 Enables Human Lung Fibroblasts to Respond to Leukotriene C4 and Produce Eotaxin J. Immunol., April 15, 2003; 170(8): 4290 - 4295. [Abstract] [Full Text] [PDF]

				W. M. Abraham Of Mice and Men Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 1 - 4. [Full Text] [PDF]

				S.-Y. Eum, K. Maghni, Q. Hamid, H. Campbell, D. H. Eidelman, and J. G. Martin Involvement of the Cysteinyl-Leukotrienes in Allergen-Induced Airway Eosinophilia and Hyperresponsiveness in the Mouse Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 25 - 32. [Abstract] [Full Text] [PDF]

				A. R. Sousa, A. Parikh, G. Scadding, C. J. Corrigan, and T. H. Lee Leukotriene-Receptor Expression on Nasal Mucosal Inflammatory Cells in Aspirin-Sensitive Rhinosinusitis N. Engl. J. Med., November 7, 2002; 347(19): 1493 - 1499. [Abstract] [Full Text] [PDF]

				R. Leigh, D. Vethanayagam, M. Yoshida, R. M. Watson, T. Rerecich, M. D. Inman, and P. M. O'Byrne Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1212 - 1217. [Abstract] [Full Text] [PDF]

				L. Ghiro, S. Zanconato, O. Rampon, V. Piovan, M.F. Pasquale, and E. Baraldi Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Eur. Respir. J., September 1, 2002; 20(3): 630 - 634. [Abstract] [Full Text] [PDF]

				R I Ketchell, M D'Amato, M W Jensen, and B J O'Connor Contrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D4 and methacholine in mild asthma Thorax, July 1, 2002; 57(7): 575 - 580. [Abstract] [Full Text] [PDF]

				W. R. HENDERSON JR., L.-O. TANG, S.-J. CHU, S.-M. TSAO, G. K. S. CHIANG, F. JONES, M. JONAS, C. PAE, H. WANG, and E. Y. CHI A Role for Cysteinyl Leukotrienes in Airway Remodeling in a Mouse Asthma Model Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 108 - 116. [Abstract] [Full Text] [PDF]

				G. M. GAUVREAU, K. N. PARAMESWARAN, R. M. WATSON, and P. M. O'BYRNE Inhaled Leukotriene E4, But Not Leukotriene D4, Increased Airway Inflammatory Cells in Subjects with Atopic Asthma Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1495 - 1500. [Abstract] [Full Text] [PDF]

				A. L. ECHAZARRETA, B. DAHLEN, G. GARCIA, C. AGUSTI, J. A. BARBERA, J. ROCA, S.-E. DAHLEN, and R. RODRIGUEZ-ROISIN Pulmonary Gas Exchange and Sputum Cellular Responses to Inhaled Leukotriene D4 in Asthma Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 202 - 206. [Abstract] [Full Text] [PDF]

				H. Bisgaard Leukotriene Modifiers in Pediatric Asthma Management Pediatrics, February 1, 2001; 107(2): 381 - 390. [Abstract] [Full Text]

				D. J. FIGUEROA, R. M. BREYER, S. K. DEFOE, S. KARGMAN, B. L. DAUGHERTY, K. WALDBURGER, Q. LIU, M. CLEMENTS, Z. ZENG, G. P. O'NEILL, et al. Expression of the Cysteinyl Leukotriene 1 Receptor in Normal Human Lung and Peripheral Blood Leukocytes Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 226 - 233. [Abstract] [Full Text]

				A. DEYKIN, O. BELOSTOTSKY, C. HONG, A. F. MASSARO, C. M. LILLY, and E. ISRAEL Exhaled Nitric Oxide following Leukotriene E4 and Methacholine Inhalation in Patients with Asthma Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1685 - 1689. [Abstract] [Full Text]

				G. M. GAUVREAU, G. M. RONNEN, R. M. WATSON, and P. M. O'BYRNE Exercise-induced Bronchoconstriction Does Not Cause Eosinophilic Airway Inflammation or Airway Hyperresponsiveness in Subjects with Asthma Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1302 - 1307. [Abstract] [Full Text] [PDF]

				A P Sampson, S Siddiqui, D Buchanan, P H Howarth, S T Holgate, J W Holloway, and I Sayers Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast Thorax, October 1, 2000; 55(90002): 28S - 31. [Full Text]

				A. R Leff Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways Thorax, October 1, 2000; 55(90002): 32S - 37. [Full Text]

				J. CHRISTIAN VIRCHOW Jr., A. PRASSE, I. NAYA, L. SUMMERTON, A. HARRIS, and The Zafirlukast Study Group Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 578 - 585. [Abstract] [Full Text] [PDF]

				I. Campbell Smoking cessation Thorax, August 1, 2000; 55(90001): S28 - 31. [PDF]

				P. Kesteven Traveller's thrombosis Thorax, August 1, 2000; 55(90001): S32 - 36. [PDF]

				A. J. MACFARLANE, R. DWORSKI, J. R. SHELLER, I. D. PAVORD, A. BARRY KAY, and N. C. BARNES Sputum Cysteinyl Leukotrienes Increase 24 Hours after Allergen Inhalation in Atopic Asthmatics Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1553 - 1558. [Abstract] [Full Text]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				P. M. O'BYRNE Why Does Airway Inflammation Persist? Is It Leukotrienes? Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S186 - 187. [Full Text] [PDF]

				S.-E. DAHLEN Pharmacological Characterization of Leukotriene Receptors Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S41 - 45. [Full Text] [PDF]

				P. M. O'BYRNE Leukotriene Bronchoconstriction Induced by Allergen and Exercise Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S68 - 72. [Full Text] [PDF]

				A. R. LEFF Role of Leukotrienes in Bronchial Hyperresponsiveness and Cellular Responses in Airways Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S125 - 132. [Full Text] [PDF]

				S. T. HOLGATE and A. P. SAMPSON Antileukotriene Therapy . Future Directions Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S147 - 153. [Full Text] [PDF]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				A. MULDER, G. M. GAUVREAU, R. M. WATSON, and P. M. O'BYRNE Effect of Inhaled Leukotriene D4 on Airway Eosinophilia and Airway Hyperresponsiveness in Asthmatic Subjects Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1562 - 1567. [Abstract] [Full Text] [PDF]

				J. M. Drazen, E. Israel, and P. M. O'Byrne Treatment of Asthma with Drugs Modifying the Leukotriene Pathway N. Engl. J. Med., January 21, 1999; 340(3): 197 - 206. [Full Text] [PDF]

				G. M. GAUVREAU, R. M. WATSON, and P. M. O'BYRNE Protective Effects of Inhaled PGE2 on Allergen-induced Airway Responses and Airway Inflammation Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 31 - 36. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				B. DAHLEN, E. NIZANKOWSKA, A. SZCZEKLIK, O. ZETTERSTROM, G. BOCHENEK, M. KUMLIN, L. MASTALERZ, G. PINIS, L. J. SWANSON, T. I. BOODHOO, et al. Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1187 - 1194. [Abstract] [Full Text] [PDF]